CH679210A5 - - Google Patents

Download PDF

Info

Publication number
CH679210A5
CH679210A5 CH3835/89A CH383589A CH679210A5 CH 679210 A5 CH679210 A5 CH 679210A5 CH 3835/89 A CH3835/89 A CH 3835/89A CH 383589 A CH383589 A CH 383589A CH 679210 A5 CH679210 A5 CH 679210A5
Authority
CH
Switzerland
Prior art keywords
percent
component
composition
eye
amount
Prior art date
Application number
CH3835/89A
Other languages
German (de)
English (en)
Inventor
Ronald Edward Peeples
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH679210A5 publication Critical patent/CH679210A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CH3835/89A 1988-10-26 1989-10-24 CH679210A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (1)

Publication Number Publication Date
CH679210A5 true CH679210A5 (xx) 1992-01-15

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3835/89A CH679210A5 (xx) 1988-10-26 1989-10-24

Country Status (24)

Country Link
JP (1) JPH02164830A (xx)
KR (1) KR900005973A (xx)
AU (1) AU626928B2 (xx)
BE (1) BE1003578A4 (xx)
CA (1) CA2001502A1 (xx)
CH (1) CH679210A5 (xx)
DE (1) DE3935517A1 (xx)
DK (1) DK531289A (xx)
ES (1) ES2020032A6 (xx)
FI (1) FI895064A0 (xx)
FR (1) FR2638089A1 (xx)
GB (1) GB2224205B (xx)
GR (1) GR1000611B (xx)
HU (1) HU203046B (xx)
IL (1) IL92120A (xx)
IT (1) IT1237824B (xx)
LU (1) LU87613A1 (xx)
MY (1) MY106271A (xx)
NL (1) NL8902657A (xx)
NO (1) NO894266L (xx)
NZ (1) NZ231131A (xx)
PT (1) PT92120B (xx)
SE (1) SE8903583L (xx)
ZA (1) ZA898140B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
WO1993023010A1 (en) * 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
ES2229473T3 (es) 1997-01-30 2005-04-16 Novartis Ag Composiciones farmaceuticas sin aceite que contienen ciclosporina a.
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
MX2010004366A (es) * 2007-11-05 2010-05-05 Bausch & Lomb Materiales inmiscibles en agua como vehiculos para suministro de farmacos.
NO2437762T3 (xx) * 2009-06-05 2018-01-06
KR102487299B1 (ko) 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
NO894266L (no) 1990-04-27
SE8903583L (sv) 1990-04-27
HU895444D0 (en) 1990-01-28
GB8924040D0 (en) 1989-12-13
CA2001502A1 (en) 1990-04-26
DK531289D0 (da) 1989-10-25
IL92120A (en) 1994-02-27
ZA898140B (en) 1991-06-26
MY106271A (en) 1995-04-29
GR890100690A (en) 1990-11-29
FR2638089A1 (fr) 1990-04-27
NO894266D0 (no) 1989-10-26
NL8902657A (nl) 1990-05-16
GB2224205B (en) 1992-04-15
PT92120B (pt) 1995-06-30
LU87613A1 (fr) 1991-05-07
JPH02164830A (ja) 1990-06-25
IT8948485A0 (it) 1989-10-26
AU4371589A (en) 1990-05-03
HUT52394A (en) 1990-07-28
HU203046B (en) 1991-05-28
IL92120A0 (en) 1990-07-12
GB2224205A (en) 1990-05-02
ES2020032A6 (es) 1991-07-16
KR900005973A (ko) 1990-05-07
FI895064A0 (fi) 1989-10-25
GR1000611B (el) 1992-08-31
NZ231131A (en) 1992-06-25
PT92120A (pt) 1990-04-30
DK531289A (da) 1990-04-27
DE3935517A1 (de) 1990-05-03
BE1003578A4 (fr) 1992-04-28
AU626928B2 (en) 1992-08-13
IT1237824B (it) 1993-06-18
SE8903583D0 (sv) 1989-10-26

Similar Documents

Publication Publication Date Title
CH679210A5 (xx)
DE69522104T2 (de) Tränendrüsen spezifische emulsion zur topischen anwendung an okulären geweben
DE69307505T2 (de) Opthalmische zusammensetzungen enthaltend ein cyclosporin
DE69328368T2 (de) Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge
EP0616801B1 (de) Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich
DE3915617B4 (de) Verwendung einer ein Cyclosporin enthaltenden Zusammensetzung zur topischen Applikation
DE69115990T2 (de) Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
DE69531389T2 (de) Cyclosporin enthaltende multiple Emulsionen
DE3785602T2 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
DE60210568T2 (de) Coenzym Q10 zur Behandlung von Erkrankungen der Augen
CH679118A5 (xx)
DE69711267T2 (de) Cyclosporin enthaltende Weichkapselpräparate
DE3850778T2 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE2902863A1 (de) Waessriges gel zur anwendung im bindehautsack
EP0585896A1 (de) Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
DE69002946T2 (de) Paracetamol enthaltende arzneizubereitung.
DE3815581A1 (de) Ophthalmologische zusammensetzung
DE69130832T2 (de) Injizierbare amphotericin b enthaltende dispersion
DE69013431T2 (de) Anthocyanidine zur Behandlung von Augenkrankheiten.
DE3643119A1 (de) Therapeutische zusammensetzung fuer diabetes-komplikationen
DE60005992T2 (de) Verwendung von ubiquinon q 10 zur vorbeugung und behandlung von postoperativen okularen pathologien
DE69428967T2 (de) Pharmazeutische emulsionen, die bioaktive steroide enthalten
DE60027878T2 (de) Verwendung des nervenwachstumfaktors zur herstellung eines arzneimittels zur behandlung von erkrankungen der innenaugegeweb
DE3688503T2 (de) Erhöhung des ausfliessens wässriger körperfluessigkeit.
DE60304458T2 (de) Verwendung eines l-ascorbinsäuresalzes zur herstellung einer pharmazeutischen zusammensetzung für die ophthalmische topische anwendung zur verbesserung des l-ascorbinsäurespiegels im auge

Legal Events

Date Code Title Description
PL Patent ceased